Search for other papers by Nelma Veronica Marques in
Google Scholar
PubMed
Search for other papers by Luiz Eduardo Armondi Wildemberg in
Google Scholar
PubMed
Search for other papers by Monica R Gadelha in
Google Scholar
PubMed
normalising insulin-like growth factor 1 (IGF1) levels that are inadequately controlled by octreotide or lanreotide ( 2 ). Long-term outcomes from clinical studies have demonstrated effective and consistent biochemical control with pasireotide for up to 304
Department of Child and Adolescent Medicine, Section of Pediatric Cardiology, University Hospital Jena, Am Klinikum, Jena, Germany
Search for other papers by Alexandra Kiess in
Google Scholar
PubMed
Search for other papers by Jessica Green in
Google Scholar
PubMed
Search for other papers by Anja Willenberg in
Google Scholar
PubMed
Search for other papers by Uta Ceglarek in
Google Scholar
PubMed
Search for other papers by Ingo Dähnert in
Google Scholar
PubMed
Department of Women and Child Health, Hospital for Children and Adolescents and Center for Pediatric Research (CPL), University of Leipzig, Liebigstrasse, Leipzig, Germany
Search for other papers by Wieland Kiess in
Google Scholar
PubMed
Department of Women and Child Health, Hospital for Children and Adolescents and Center for Pediatric Research (CPL), University of Leipzig, Liebigstrasse, Leipzig, Germany
Search for other papers by Mandy Vogel in
Google Scholar
PubMed
heart disease and HF, serum IGF-1 and IGF-binding protein 3 (BP3) levels were negatively correlated with serum troponin I levels ( 6 ). As part of the prospective longitudinal population-based cohort study, ‘LIFE Child’ in Leipzig, Germany, we recently
Search for other papers by Djeda Belharazem in
Google Scholar
PubMed
Institute of Pathology, Institute of Pathology Nordhessen, Institute of Transfusion Medicine and Immunology, Departments of Urology and Pediatric Urology, University Medical Center Mannheim, Institute of Pathology, University Medical Center Mannheim, University of Heidelberg, Theodor-Kutzer-Ufer 1–3, 68135 Mannheim, Germany
Search for other papers by Matthias Kirchner in
Google Scholar
PubMed
Search for other papers by Franziska Geissler in
Google Scholar
PubMed
Search for other papers by Peter Bugert in
Google Scholar
PubMed
Search for other papers by Martin Spahn in
Google Scholar
PubMed
Search for other papers by Burkhard Kneitz in
Google Scholar
PubMed
Search for other papers by Hubertus Riedmiller in
Google Scholar
PubMed
Search for other papers by Christian Sauer in
Google Scholar
PubMed
Search for other papers by Stefan Küffer in
Google Scholar
PubMed
Search for other papers by Lutz Trojan in
Google Scholar
PubMed
Search for other papers by Christian Bolenz in
Google Scholar
PubMed
Search for other papers by Maurice Stephan Michel in
Google Scholar
PubMed
Search for other papers by Alexander Marx in
Google Scholar
PubMed
Institute of Pathology, Institute of Pathology Nordhessen, Institute of Transfusion Medicine and Immunology, Departments of Urology and Pediatric Urology, University Medical Center Mannheim, Institute of Pathology, University Medical Center Mannheim, University of Heidelberg, Theodor-Kutzer-Ufer 1–3, 68135 Mannheim, Germany
Search for other papers by Philipp Ströbel in
Google Scholar
PubMed
genes known to date, the insulin-like growth factor 2 ( IGF2 ) and H19 , a gene for a noncoding RNA, are probably studied best (9) . IGF2 is of special interest, as it belongs to a small set of imprinted genes that can be studied in peripheral blood
Search for other papers by Rossella Cannarella in
Google Scholar
PubMed
Search for other papers by Andrea Crafa in
Google Scholar
PubMed
Search for other papers by Sandro La Vignera in
Google Scholar
PubMed
Search for other papers by Rosita A Condorelli in
Google Scholar
PubMed
Search for other papers by Aldo E Calogero in
Google Scholar
PubMed
acromegalic levels of IGF-I during puberty? Journal of Clinical Endocrinology and Metabolism 2019 104 2770 – 2776 . ( https://doi.org/10.1210/jc.2018-02099 ) 2 Chandrashekar V Zaczek D Bartke A . The consequences of altered somatotropic system
Search for other papers by Robert Rapaport in
Google Scholar
PubMed
Search for other papers by Peter A Lee in
Google Scholar
PubMed
Nemours/DuPont Hospital for Children, Wilmington, Delaware, USA
Search for other papers by Judith L Ross in
Google Scholar
PubMed
Search for other papers by Paul Saenger in
Google Scholar
PubMed
Search for other papers by Vlady Ostrow in
Google Scholar
PubMed
Search for other papers by Giuseppe Piccoli in
Google Scholar
PubMed
(eg, HSDS, age, insulin-like growth factor 1 (IGF-I) SDS) on changes in HSDS in response to GH therapy over time ( 12 , 13 ). The analysis described here evaluated growth outcomes (HSDS, IGF-I SDS and BMI SDS), bone age per chronological age (BA
Search for other papers by Caiyan Mo in
Google Scholar
PubMed
Search for other papers by Tao Tong in
Google Scholar
PubMed
Search for other papers by Ying Guo in
Google Scholar
PubMed
Search for other papers by Zheng Li in
Google Scholar
PubMed
Search for other papers by Liyong Zhong in
Google Scholar
PubMed
included TSS, bromocriptine, or cabergoline for GHPA, and ATD or 131I for GD. Table 2 Cases of GHPA combined with GD in the published literature. Author Year Country Age (years)/ gender Clinical manifestations GH (ng/mL) IGF-1
Search for other papers by Antonella Giampietro in
Google Scholar
PubMed
Search for other papers by Sabrina Chiloiro in
Google Scholar
PubMed
Search for other papers by Claudio Urbani in
Google Scholar
PubMed
Search for other papers by Rosario Pivonello in
Google Scholar
PubMed
Search for other papers by Martin Ove Carlsson in
Google Scholar
PubMed
Search for other papers by Francesca Dassie in
Google Scholar
PubMed
Search for other papers by Nunzia Prencipe in
Google Scholar
PubMed
Search for other papers by Marta Ragonese in
Google Scholar
PubMed
Search for other papers by Roy Gomez in
Google Scholar
PubMed
Search for other papers by Simona Granato in
Google Scholar
PubMed
Search for other papers by Salvatore Cannavò in
Google Scholar
PubMed
Search for other papers by Silvia Grottoli in
Google Scholar
PubMed
Search for other papers by Pietro Maffei in
Google Scholar
PubMed
Search for other papers by Annamaria Colao in
Google Scholar
PubMed
Search for other papers by Fausto Bogazzi in
Google Scholar
PubMed
Search for other papers by Antonio Bianchi in
Google Scholar
PubMed
nerve palsies, intracranial hypertension and rhinoliquorrhea. This investigation was based on the complete analysis set of ACROSTUDY, including data from 15 countries for a total of 2221 enrolled patients. Information on IGF-1 status (i.e. below the
Search for other papers by Julie M Silverstein in
Google Scholar
PubMed
2014 10 243 – 248 . ( doi:10.1038/nrendo.2014.21 ). 16 Holdaway IM Bolland MJ Gamble GD . A meta-analysis of the effect of lowering serum levels of GH and IGF-I on mortality in acromegaly . European Journal of Endocrinology 2008 159 89
Priority Research Centre for Cancer, School of Biomedical Sciences and Pharmacy, Faculty of Health and Medicine, University of Newcastle, Newcastle, New South Wales, Australia
Search for other papers by Katherine A Bolton in
Google Scholar
PubMed
Priority Research Centre for Cancer, School of Biomedical Sciences and Pharmacy, Faculty of Health and Medicine, University of Newcastle, Newcastle, New South Wales, Australia
Search for other papers by Kelly A Avery-Kiejda in
Google Scholar
PubMed
Clinical Research Design, IT and Statistical Support Unit, Hunter Medical Research Institute, Newcastle, New South Wales, Australia
Search for other papers by Elizabeth G Holliday in
Google Scholar
PubMed
Clinical Research Design, IT and Statistical Support Unit, Hunter Medical Research Institute, Newcastle, New South Wales, Australia
Search for other papers by John Attia in
Google Scholar
PubMed
Priority Research Centre for Cancer, School of Biomedical Sciences and Pharmacy, Faculty of Health and Medicine, University of Newcastle, Newcastle, New South Wales, Australia
Search for other papers by Nikola A Bowden in
Google Scholar
PubMed
Priority Research Centre for Cancer, School of Biomedical Sciences and Pharmacy, Faculty of Health and Medicine, University of Newcastle, Newcastle, New South Wales, Australia
Molecular Medicine, Pathology North, John Hunter Hospital, Newcastle, New South Wales, Australia
Discipline of Medical Genetics, School of Biomedical Sciences and Pharmacy, Faculty of Health and Medicine, University of Newcastle, University Drive, Newcastle, New South Wales, Australia
Search for other papers by Rodney J Scott in
Google Scholar
PubMed
143 – 163 . ( doi:10.1210/edrv-16-2-143 ) 17 Laban C Bustin SA Jenkins PJ. The GH-IGF-I axis and breast cancer . Trends in Endocrinology & Metabolism 2003 14 28 – 34 . ( doi:10.1016/S1043-2760(02)00003-6 ) 18 Chen X Guan J
Search for other papers by Bernardo Maia in
Google Scholar
PubMed
Neuroendocrinology Division – Instituto Estadual do Cérebro Paulo Niemeyer, Rio de Janeiro, Brazil
Endocrinology Division – Hospital Federal de Bonsucesso, Rio de Janeiro Brazil
Search for other papers by Leandro Kasuki in
Google Scholar
PubMed
Neuroendocrinology Division – Instituto Estadual do Cérebro Paulo Niemeyer, Rio de Janeiro, Brazil
Neuropatology and Molecular Genetics Laboratory – Instituto Estadual do Cérebro Paulo Niemeyer, Rio de Janeiro, Brazil
Search for other papers by Mônica R Gadelha in
Google Scholar
PubMed
Introduction Acromegaly is a chronic systemic rare disease most commonly caused by a somatotroph pituitary adenoma with autonomous overproduction of growth hormone (GH) and a consequent increase in insulin-like growth factor type I (IGF-I